Compare Amphastar Pharmaceuticals Inc (AMPH) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Prudential Financial Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $863.95M), while Prudential Financial Inc trades at $122.19 (market cap $42.13B). The key difference: Prudential Financial Inc is far larger — about 48.8× Amphastar Pharmaceuticals Inc's market cap, and Prudential Financial Inc pays a 4.59% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | PRU | |
|---|---|---|
Market Cap | $863.95M | $42.13B |
Sector | Health | Financials |
52-Week High | $30.81 | $123.93 |
52-Week Low | $16.87 | $92.00 |
Enterprise Value | $1.26B | $70.91B |
Dividend Yield | — | 4.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Prudential Financial (PRU) trades at $121.28, down 0.18% today, with a bullish technical signal from moving averages and ADX indicators. The stock shows strong fundamentals with a P/E of 11 and net income margin of 6.04%, supported by Q2 2026 earnings beating estimates. Recent news highlights strategic refocusing and institutional buying interest, though China tax concerns caused temporary volatility.
Outlook remains positive due to earnings beats and capital-light strategy, but risks include interest rate sensitivity and geopolitical exposure. Analyst consensus is cautious with a $110 price target below current levels, suggesting limited upside despite solid operational performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
